Error-enhanced Learning & Recovery in 2 & 3 Dimensions
Launched by SHIRLEY RYAN ABILITYLAB · Dec 17, 2021
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
**Study Summary: Error-Enhanced Learning & Recovery in 2 & 3 Dimensions**
This clinical trial is exploring how making mistakes during specific exercises can actually help improve movement after a stroke. Participants will practice reaching for targets with their affected arm, and the researchers will observe the errors they make. By understanding these errors, the team aims to create personalized exercise programs that target each individual's specific challenges, ultimately helping them move better over time.
To participate in this study, you need to be at least 18 years old and have had a stroke for more than eight months, with some ability to move your shoulder and elbow. You should also have weakness on one side of your body. Unfortunately, this study cannot include individuals with severe movement difficulties, certain cognitive or sensory impairments, or those currently involved in other rehabilitation treatments. If eligible, participants can expect to engage in customized exercises designed to enhance their recovery while contributing to valuable research that could help others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. 18 years of age or older
- • 2. Chronic stroke (8+ months post stroke event) with primary motor cortex involvement
- • 3. Hemiparesis
- • 4. Some degree of both shoulder and elbow movement capability
- Exclusion Criteria:
- • 1. Bilateral paresis
- • 2. Severe tactile deficits using the Two-Point Discrimination Test (participant must detect\<11mm)
- • 3. Severe proprioceptive deficits
- • 4. Severe spasticity (Modified Ashworth \>3) preventing movement
- • 5. Aphasia, cognitive impairment, or affective dysfunction that would influence the ability to perform the experiment
- • 6. Visual deficits, and hemispatial neglect that would prevent the subjects from seeing the targets.
- • 7. Inability to provide an informed consent
- • 8. severe current medical problems
- • 9. diffuse/multiple lesion sites or multiple stroke events
- • 10. Inability to attain and maintain testing positions
- • 11. Botox injection to the affected upper extremity within the previous 4 months
- • 12. Concurrent participation in upper extremity rehabilitation either as part of a research intervention protocol or a prescribed therapy
- • 13. Participation in previous, similar robotics intervention study
- • 14. Other neurological issues
- None of the following special populations will be included in this research study:
- • Adults unable to consent
- • Individuals who are not yet adults (infants, children, teenagers)
- • Pregnant women
- • Prisoners
- • Vulnerable Populations
About Shirley Ryan Abilitylab
Shirley Ryan AbilityLab is a leading research and rehabilitation institute dedicated to advancing the science of physical medicine and rehabilitation. Based in Chicago, Illinois, the organization integrates clinical care, research, and education to enhance the quality of life for individuals with disabilities and chronic conditions. Known for its innovative approach, Shirley Ryan AbilityLab conducts clinical trials that aim to develop and evaluate cutting-edge therapies and technologies, fostering a collaborative environment that bridges the gap between laboratory research and patient care. Through its commitment to excellence, the institute strives to empower patients and improve outcomes in rehabilitation medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Chicago, Illinois, United States
Patients applied
Trial Officials
James Patton, PhD
Principal Investigator
Shirley Ryan AbilityLab
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials